Vasomedical, Inc. - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Vasomedical, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Vasomedical, Inc.. The Group's principal activities are to design, manufacture and market and support Enhanced External Counterpulsation system (EECP). EECP systems based on proprietary technology currently indicated for use in cases of stable and unstable angina (chest pain), congestive heart failure (CHF), acute myocardial infarction (heart attack) and cardiogenic shock. The products of the Group are sold to treatment providers in the United States through a direct sales force. The Group also provides hospitals, clinics and physician private practices with EECP equipment, treatment guidance and a staff training and equipment maintenance program designed to provide optimal patient outcomes. The Group distributes its product internationally through a network of independent distributors.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report